NorInvent Overview

  • Status
  • Private
  • Employees
  • 1
  • Latest Deal Type
  • IPO

NorInvent General Information


Developer of a drug delivery platform designed to administer drugs in the body. The company's platform develops technologies to streamline, customize and control carbohydrate chains so that it can act as carriers/transporters of drugs, enabling drug manufacturers to make medicine that can be routed to any desired location in the body and do its work.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Delivery
Primary Office
  • Medicon Village
  • Scheelevägen 2
  • 223 81 Lund
  • Sweden
+46 000000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NorInvent Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. IPO 23-May-2017 Completed Generating Revenue
1. Accelerator/Incubator 03-Nov-2015 Completed Startup
To view NorInvent’s complete valuation and funding history, request access »

NorInvent Board Members (7)

Name Representing Role Since
Bengt Johansson Self Chairman 000 0000
Bo Kollberg NorInvent Chairman 000 0000
Gosta Hiller NorInvent Board Member 000 0000
Ingela Stenberg NorInvent Board Member 000 0000
Joel Karlsson NorInvent Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

NorInvent Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial